Scroll To Top
Health

White House to shift AIDS research funds to anthrax program

White House to shift AIDS research funds to anthrax program

Support The Advocate
We're asking for your help to continue our newsroom's important reporting. Support LGBTQ+ journalism by contributing today!

The Bush administration has ordered the National Institutes of Health to shift millions in funding from existing research projects, including those for AIDS, to efforts aimed at developing a new anthrax vaccine, Newsday reports. More than 500 researchers will be affected by the shift in funding caused by the Bush administration's mandate to develop an anthrax vaccine that came with no additional financial allocations from Congress. In order to pay for the new research, funds will be diverted from existing research programs on AIDS, tuberculosis, malaria, and other infectious diseases. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said the decree by the Administration is "unprecedented" in its call for a major new scientific research project without any financial support for it. Although an anthrax vaccine already exists, Bush and some members of Congress have pushed for the creation of a new vaccine based on more advanced technology. According to the Infectious Diseases Society of America, four-year research projects in other areas will likely be shortened to 3 1/2 years and two-year projects reduced to 1 1/2 years to pay for the anthrax initiative. "We're not happy about it, but we tried to do what was least painful," Fauci said.

Stonewall Brick AwardsOut / Advocate Magazine - Jonathan Groff & Wayne Brady

From our Sponsors

Most Popular

Latest Stories

Advocate.com Editors